Type II Alveolar Cells | Pulmonary Surfactant

The video tutorial explains the differences between Type 1 and Type 2 alveolar cells, focusing on the role of Type 2 cells in producing pulmonary surfactant. This surfactant is crucial in reducing surface tension within the alveoli, preventing their collapse and ensuring efficient gas exchange. The tutorial also discusses the challenges faced by premature infants who lack the ability to produce surfactant, leading to potential respiratory issues. Solutions such as ventilators and surfactant injections are highlighted as interventions for these infants.

What is the primary structural difference between Type 1 and Type 2 alveolar cells?

• Type 1 cells are cylindrical, while Type 2 cells are cuboidal.

• Type 1 cells are squamous, while Type 2 cells are cuboidal.

• Type 1 cells are cuboidal, while Type 2 cells are squamous.

• Type 1 cells are cuboidal, while Type 2 cells are cylindrical.

What causes surface tension inside the alveolus?

• The presence of lipid molecules.

• Hydrogen bonding between water molecules.

• The presence of carbon dioxide molecules.

• The presence of oxygen molecules.

What is the main function of pulmonary surfactant?

• To facilitate the collapse of the alveolus.

• To break hydrogen bonds between water molecules.

• To increase the surface tension in the alveolus.

• To increase the thickness of the alveolar walls.

Why is pulmonary surfactant crucial for gas exchange?

• It removes water molecules from the alveolus.

• It increases the surface tension.

• It prevents the alveolus from collapsing.

• It thickens the alveolar walls.

What is a common issue faced by premature infants regarding their respiratory system?

• They have an excess of Type 1 alveolar cells.

• They produce too much pulmonary surfactant.

• They have too many water molecules in the alveolus.

• They lack the ability to produce pulmonary surfactant.

What is one solution for premature infants who cannot produce pulmonary surfactant?

• Reducing the number of water molecules in the alveolus.

• Increasing the number of Type 1 alveolar cells.

• Providing oxygen therapy.

• Using a ventilator to assist breathing.

What is another method to help premature infants with respiratory issues?

• Administering injections of pulmonary surfactant.

• Increasing the surface tension in the alveolus.

• Reducing the number of Type 2 alveolar cells.

• Providing carbon dioxide therapy.